窥得儿医药（QuidelOrtho）今日盘前股价大涨5.22%，引起投资者关注。
消息面上，窥得儿医药公布了截至3月31日的季度业绩报告。数据显示，公司调整后每股收益为0.74美元，大幅高于去年同期的0.44美元，也超过了分析师平均预期的0.59美元。尽管季度营收同比小幅下降2.6%至6.93亿美元，但仍高于市场预期的6.90亿美元。
这份亮眼的财报似乎暂时缓解了投资者的担忧。值得注意的是，窥得儿医药股价在过去一个季度下跌了25.8%，今年以来更是累计下跌41.8%。然而，分析师对公司前景仍保持乐观态度，目前对该股的平均评级为"买入"，12个月目标价中位数为54美元，显示出对公司长期发展的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.